ZA984314B - Clear injectable formulation of an anaesthetic compound - Google Patents

Clear injectable formulation of an anaesthetic compound

Info

Publication number
ZA984314B
ZA984314B ZA984314A ZA984314A ZA984314B ZA 984314 B ZA984314 B ZA 984314B ZA 984314 A ZA984314 A ZA 984314A ZA 984314 A ZA984314 A ZA 984314A ZA 984314 B ZA984314 B ZA 984314B
Authority
ZA
South Africa
Prior art keywords
injectable formulation
anaesthetic compound
clear
clear injectable
anaesthetic
Prior art date
Application number
ZA984314A
Other languages
English (en)
Inventor
Vincenzo De Tommaso
Original Assignee
Saucy Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saucy Limited filed Critical Saucy Limited
Publication of ZA984314B publication Critical patent/ZA984314B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA984314A 1997-05-26 1998-05-21 Clear injectable formulation of an anaesthetic compound ZA984314B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.

Publications (1)

Publication Number Publication Date
ZA984314B true ZA984314B (en) 1998-12-08

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984314A ZA984314B (en) 1997-05-26 1998-05-21 Clear injectable formulation of an anaesthetic compound

Country Status (23)

Country Link
US (1) US6326406B1 (xx)
EP (1) EP0991405B1 (xx)
JP (1) JP2001527577A (xx)
KR (1) KR20010013011A (xx)
CN (1) CN1268051A (xx)
AR (1) AR012853A1 (xx)
AT (1) ATE230984T1 (xx)
AU (1) AU735020B2 (xx)
BR (1) BR9809492A (xx)
CA (1) CA2291261A1 (xx)
CH (1) CH692322A5 (xx)
DE (1) DE69810771D1 (xx)
DZ (1) DZ2503A1 (xx)
HU (1) HUP0002117A3 (xx)
IN (1) IN187550B (xx)
MY (1) MY132911A (xx)
NO (1) NO995831L (xx)
PA (1) PA8451701A1 (xx)
PE (1) PE75299A1 (xx)
PL (1) PL337026A1 (xx)
TR (1) TR200000116T2 (xx)
WO (1) WO1998053805A1 (xx)
ZA (1) ZA984314B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
PT1143962E (pt) * 1999-01-28 2005-03-31 Kurani Shashikant Prabhudas Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
CN104587479A (zh) 2002-12-09 2015-05-06 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
CN103054798B (zh) 2005-08-31 2021-03-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
NZ592132A (en) 2005-08-31 2012-12-21 Abraxis Bioscience Llc Composition comprising nanoparticles of docitaxel and a citrate
NZ590802A (en) * 2008-11-20 2013-05-31 Techno Guard Co Ltd Formulation comprising a pyrazolone derivative and an amphiphilic solubilising agent
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
WO2019173526A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
CH692322A5 (it) 2002-05-15
MY132911A (en) 2007-10-31
PA8451701A1 (es) 2000-05-24
DE69810771D1 (de) 2003-02-20
ATE230984T1 (de) 2003-02-15
TR200000116T2 (tr) 2000-05-22
PE75299A1 (es) 1999-08-26
IN187550B (xx) 2002-05-18
EP0991405A1 (en) 2000-04-12
BR9809492A (pt) 2000-06-20
US6326406B1 (en) 2001-12-04
HUP0002117A3 (en) 2001-04-28
NO995831D0 (no) 1999-11-26
EP0991405B1 (en) 2003-01-15
HUP0002117A2 (hu) 2000-12-28
NO995831L (no) 2000-01-26
WO1998053805A1 (en) 1998-12-03
AU8209798A (en) 1998-12-30
PL337026A1 (en) 2000-07-31
DZ2503A1 (fr) 2005-01-25
CA2291261A1 (en) 1998-12-03
KR20010013011A (ko) 2001-02-26
CN1268051A (zh) 2000-09-27
JP2001527577A (ja) 2001-12-25
AU735020B2 (en) 2001-06-28
AR012853A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
ZA984314B (en) Clear injectable formulation of an anaesthetic compound
EP0785713A4 (en) PRODUCTION OF AEROSOL FORMULATION OF INSULIN
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AU6883798A (en) Method of anesthesia
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
ZA987800B (en) Pharmaceutical composition of meloxicam
AU7389098A (en) Local anesthetic formulations
EG24071A (en) Injectable quinolone formulations
ZA985096B (en) Composition compound and use
EP0976407A4 (en) ANTISEPTIC COMPOSITIONS
EP0978288A4 (en) DRUG COMPOSITION
HUP0004665A3 (en) Anaesthetic formulation
GB9701674D0 (en) Use of organic compounds
PL337804A1 (en) Solubilised compositions of sertralin
ZA986465B (en) Preparation of fluorinated compounds
SI1032390T1 (en) Anaesthetic formulation
EG21166A (en) Solubilization of boric acid
PL327430A1 (en) Set of shaped components
TW364360U (en) Improvement on structure of syringe
AUPO528897A0 (en) Anaesthetic compositions
AUPO780497A0 (en) Anaesthetic compositions
GB9818109D0 (en) Anaesthetic Formulation
EP0981368A4 (en) COLONIZATION FACTORS MASS SPECTROSCOPY
GB9722026D0 (en) Use of compounds
GB9719092D0 (en) Preparation of fluorinated organic compounds